# FDA 483 - Norman Lepor - May 28, 2014

Source: https://www.keypedia.com/records/483/norman-lepor/c966a475-dce7-4c24-b47e-78ad1d91fc98

> FDA 483 for Norman Lepor on May 28, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Norman Lepor
- Inspection Date: 2014-05-28
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Dr. Norman E. Lepor, a Principal Investigator at Westside Medical Associates of LA, identified an issue with investigational drug disposition records. Specifically, the records for a study lacked complete information regarding the dates and quantities of drugs returned by subjects. This indicates a deficiency in maintaining adequate documentation for clinical trials.

## Related Officers

- [investigator](https://www.keypedia.com/people/comyar-shoghi/c172c1bc-deea-4bed-a3cf-5493d72ce6c3)

Company: https://www.keypedia.com/companies/norman-lepor/8b067220-ffbe-4541-9b4f-4f6a558ece58

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6